FTC approves Actavis, Warner Chilcott deal The FTC approves Actavis' ( ACT ) acquisition of Warner Chilcott ( WCRX ). As part of the deal, ACT will divest Zenchent Fe, an application for a generic version of Lo Loestrin Fe, an application for a generic version of Atelvia, and an approved application for generic Loestrin 24 Fe. ( PR ) Post your comment!
Sept. 27, 2013 - Seeking Alpha